DEREGULATION OF NF-KB/REL BY TAX & ADULT T-CELL LEUKEMIA

通过税收放松 NF-KB/REL 的管制

基本信息

  • 批准号:
    2712745
  • 负责人:
  • 金额:
    $ 18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-08-01 至 2000-05-31
  • 项目状态:
    已结题

项目摘要

Adult T-cell leukemia (ATL) is a very aggressive and often fatal T-cell malignancy that is caused by infection of the type I human T-cell leukemia virus (HTLV-I). The HTLV-I encoded Tax protein appears to play a central role in the initiation of this virally induced T-cell malignancy. Tax acts by activating cellular transcription factors, including members of the NF- 1kappaBalpha/Rel family, which in turn induces various cellular genes involved in lymphocyte activation and growth. In resting T cells, NF- kappaB/Rel factors are sequestered m the cytoplasm by various inhibitory proteins including I-kappaB-alpha, a 37 kD protein containing multiple ankyrin-like repeats. HTLV-I Tax expression results in the constitutive nuclear expression of these kappaB-enhancer binding proteins, leading to the deregulated expression the various cellular growth-related genes, which have been proposed to induce the polyclonal T-cell proliferation, a prelude to the establishment of ATL. Our recent studies suggest that Tax activation of NF-kappaB is associated with the phosphorylation and degradation of I-kappaB-alpha and the activated nuclear NF-kappaB seems, together with other yet to be identified transcriptional enhancers or silencers, to mediate the Tax-induced transcriptional induction of the c- rel proto-oncogene. We have further observed that these Tax-induced cellular events can be blocked by various inhibitors of cellular signal transduction. Together, these results raise the possibility that Tax may induce a specific cellular signal transduction pathway leading to a cascade of both cytoplasmic and nuclear reactions with phosphorylation of IkBa serving as a molecular trigger. This specific action of Tax results in the nuclear expression of both NF-kB and c-Rel. Based on these results, the overall objective of this grant proposal is a fundamental understanding of the Tax-mediated NF-kappaB/Rel induction signaling pathway. To approach this overall objective, a set of biochemical studies will be undertaken to precisely map the sites of Tax-induced phosphorylation within I-kappaB-alpha. In turn, site-directed mutations will be sequentially introduced into these sites to examine the functional significance of these phosphorylation events on Tax-mediated I-kappaB- alpha degradation. In conjunction with these site-directed mutagenesis, progressive deletional analyses will also be performed to completely define the sequences within I-kappaB-alpha that are required for protease attack. To explore the Tax-mediated signaling pathway, different strategies will be used to identify and characterize the cellular molecular components, including I-kappaB-alpha-specific kinases and the more proximal signaling molecules, involved in the Tax-mediated activation of NF-kappaB/Rel. Finally, the precise mechanism of Tax-induced transcriptional induction of c-rel gene will be explored by isolation and functional analyses of the human c-rel gene promoter.
成人T细胞白血病(ATL)是一种非常具有侵袭性且通常致命的T细胞白血病。 由I型人类T细胞白血病感染引起的恶性肿瘤 病毒(HTLV-I)。HTLV-I编码的Tax蛋白似乎起着中心作用, 在这种病毒诱导的T细胞恶性肿瘤的起始中起作用。税收法案 通过激活细胞转录因子,包括NF-κ B的成员, 1 kappaB α/Rel家族,其反过来诱导各种细胞基因 参与淋巴细胞的活化和生长。在静息T细胞中,NF- kappaB/Rel因子通过各种抑制性的细胞因子被隔离在细胞质中。 蛋白质,包括I-kappaB-α,一种37 kD的蛋白质,含有多个 类似脚踝的重复。HTLV-I Tax表达导致组成性 这些κ B增强子结合蛋白的核表达,导致 各种细胞生长相关基因的表达失调, 已经提出诱导多克隆T细胞增殖, 这是建立ATL的前奏。我们最近的研究表明, NF-κ B的活化与磷酸化有关, I-κ B-α和活化的核NF-κ B的降解似乎, 与其他尚未鉴定的转录增强子一起, 沉默子,以介导Tax诱导的c- rel原癌基因我们进一步观察到,这些税收诱导的 细胞事件可被细胞信号的各种抑制剂阻断 转导总之,这些结果提高了税收可能 诱导特异性细胞信号转导途径, 细胞质和细胞核反应的级联反应, IkBa作为分子触发器。这一具体行动的税收结果 NF-κ B和c-Rel的核表达。基于这些结果, 这项赠款提案总体目标是 Tax介导的NF-κ B/Rel诱导信号的理解 通路为了达到这一总体目标,一系列生物化学研究 将进行精确地绘制税收诱导的网站, I-κ B-α内的磷酸化。反过来,定点突变 将依次引入这些网站,以检查功能 这些磷酸化事件对Tax介导的I-kappaB- α降解结合这些定点诱变, 还将进行渐进式删除分析, 定义蛋白酶所需的I-kappaB-α内的序列 攻击为了探索Tax介导的信号通路, 策略将用于识别和表征细胞 分子组分,包括I-κ B-α特异性激酶和 更近端的信号分子,参与Tax介导的激活 NF-κ B/Rel.最后,税收诱导的确切机制 将通过分离来探索c-rel基因的转录诱导, 人c-rel基因启动子的功能分析。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shao-Cong Sun其他文献

Shao-Cong Sun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shao-Cong Sun', 18)}}的其他基金

Molecular mechanisms underlying immunosuppression and inflammation caused by SARS-CoV2 proteins
SARS-CoV2蛋白引起免疫抑制和炎症的分子机制
  • 批准号:
    10163402
  • 财政年份:
    2020
  • 资助金额:
    $ 18万
  • 项目类别:
Molecular mechanisms regulating TLR signaling and inflammation
调节 TLR 信号传导和炎症的分子机制
  • 批准号:
    10265710
  • 财政年份:
    2020
  • 资助金额:
    $ 18万
  • 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
  • 批准号:
    8660625
  • 财政年份:
    2013
  • 资助金额:
    $ 18万
  • 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
  • 批准号:
    9044725
  • 财政年份:
    2013
  • 资助金额:
    $ 18万
  • 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
  • 批准号:
    8469642
  • 财政年份:
    2013
  • 资助金额:
    $ 18万
  • 项目类别:
Molecular Mechanisms Regulating Noncanonical NF-kB Signaling
调节非典型 NF-kB 信号传导的分子机制
  • 批准号:
    7807470
  • 财政年份:
    2009
  • 资助金额:
    $ 18万
  • 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
  • 批准号:
    7150300
  • 财政年份:
    2006
  • 资助金额:
    $ 18万
  • 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
  • 批准号:
    7247127
  • 财政年份:
    2006
  • 资助金额:
    $ 18万
  • 项目类别:
Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD
去泛素酶 CYLD 对 T 细胞功能和自身免疫炎症的调节
  • 批准号:
    8289618
  • 财政年份:
    2006
  • 资助金额:
    $ 18万
  • 项目类别:
Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD
去泛素酶 CYLD 对 T 细胞功能和自身免疫炎症的调节
  • 批准号:
    8046495
  • 财政年份:
    2006
  • 资助金额:
    $ 18万
  • 项目类别:

相似海外基金

The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
  • 批准号:
    23K15977
  • 财政年份:
    2023
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
  • 批准号:
    22KJ2450
  • 财政年份:
    2023
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
  • 批准号:
    23H03151
  • 财政年份:
    2023
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    23K08067
  • 财政年份:
    2023
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
  • 批准号:
    22K19629
  • 财政年份:
    2022
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
  • 批准号:
    22K09763
  • 财政年份:
    2022
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
  • 批准号:
    20K17570
  • 财政年份:
    2020
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
  • 批准号:
    20K16311
  • 财政年份:
    2020
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    20K08953
  • 财政年份:
    2020
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
  • 批准号:
    20H03771
  • 财政年份:
    2020
  • 资助金额:
    $ 18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了